Analytical study of bacterial vaginal infections including antimicrobial assessment in Asser Region, Saudi Arabia

Paper Details

Research Paper 01/08/2016
Views (158) Download (10)
current_issue_feature_image
publication_file

Analytical study of bacterial vaginal infections including antimicrobial assessment in Asser Region, Saudi Arabia

AA Osman, NM Abdalla, HE Mubasher, MN Mohamed
Int. J. Biosci.9( 2), 126-136, August 2016.
Certificate: IJB 2016 [Generate Certificate]

Abstract

This study aimed to evaluate antimicrobial susceptibility of vaginal bacterial infections isolates in Asser region, Saudi Arabia. A cross section hospital based study was conducted. Out of 150 sample of high vaginal swab collected through three month, 15 women had bacterial vaginal infections. Each collection swab was initially inoculated into Muller Hinton agar then impregnated antibiotics filter paper was immersed after incubation 48 hrs, the antibiotics sensitivity was determined by measuring the minimum inhibitory concentration (MIC) of each antibiotic, for most common prescribed antibiotics (20drugs). The final result as follows: For E. coli, a drug which is of absolute resistance (100%) was Ampcillin and these with 100% sensitive were Nitrofurantoin and Amikacine. Sensitivity of other drugs range from 50 to75% resistance. Regarding Enterobacter, 100% resistance found in 3 drugs, Ampcillin, Augmentin and Cotrimaxcillin. While 100% sensitivity present in 5 drugs which were Nitrofurantoin, Imipenem, Gentamycin, Ciprofloxacin and Amikacin. In Klebsiella pneumoni drugs with 100% resistance were Cephalosporin, Ceftazidime, Ampcillin and Augmentin. Almost all other drugs were sensitive. The fourth organism is Staphylococcus aureus, 100% resistance found in Ampcillin Augmentin, Pencillin, Cifoxtine. 100% sensitivity in Cotrimxacillin, Tetracycline, Gentamycin and vancomycin. Last organism was Streptococcus agalactica, 100% resistance to Ampcillin, Augmentin,Tetracycline, Pencillin, erythromycin and Cifoxatine. Other drugs were 50% sensitive and 50% resistance. As conclusion, treatment of bacterial vaginosis is getting more difficult due to emerge of antibiotics resistance.

VIEWS 11

Abdalla NM. 2011. Sudanese male fertility and infections. Journal of scientica-parasitologica: September 12(3), 123-129. www.scientia.zooparaz.net/2011_12_03/sp2011-123-129-Abdalla.pdf

Aroutcheva A, Gariti D, Simon M, Shott S, Faro J, Simoes JA, et al. 2001. Defense factors of vaginal lactobacilli. American Journal of Obstetrics and Gynecology 185, 375–9. DOI: 10.1067/mob.2001.115867

Beigi RH, Austin MN, Meyn LA, Krohn MA, Hillier SL. 2004. Antimicrobial resistance associated with the treatment of bacterial vaginosis. American Journal of Obstetrics and Gynecology 191, 1124–9. DOI: 10.1016/j.ajog.2004.05.033

Bibel DJ, Aly R, Lahti L, Shinefield HR, Maibach HI. 1987. Microbial adherence to vulvar epithelial cells. Journal of Medical Microbiology 23, 75–82. DOI:10.1099/00222615-23-1-75

Busscher HJ, Weerkamp AH. 1987. Specific and non-specific interactions in bacterial adhesion to solid substrata. Journal of FEMS Microbiology Letters 46, 165–73.

Castelo-Branco C, Cancelo MJ, Villero J, Nohales F, Juliá MD. 2005 Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas Journal 52(Suppl 1): S46–52.

Darwish A, Elnshar EM, Hamadeh SM, Makarem MH. 2007. Treatment options for bacterial vaginosis in patients at high risk of preterm labor and premature rupture of membranes. Journal of Obstetrics and Gynecology Reserch 33, 781–7. DOI: 10.1111/j.1447-0756.2007.00656.x

Dickey LJ, Nailor MD, Sobel JD. 2009. Guidelines for the treatment of bacterial vaginosis: Focus on tinidazole. Journal of Therapeutics and Clinical Risk Management 5, 485–9. PMCID:PMC2710380

Dohle GR. 2003. Inflammatory-associated obstructions of the male genital tract, Andrologia Journal. 35, 321-324. PMID:14535864

Dover SE, Aroutcheva AA, Faro S, Chikindas ML. 2008. Natural antimicrobials and their role in vaginal health: A short review. International Journal of Probiotics Prebiotics 3, 219-30.

Dunkelberg WE, Jr. 1965. Diagnosis of hemophilus vaginalis vaginitis by gram-stained smears. American Journal of Obstetric and Gynecology 91, 998.

Eggert-Kruse W, Gerhard I, Naher H, Tilgen W, Runnebaum B. 1990. Chlamydial infection – a female and/or male infertility factor? Fertility and sterility Journal 53, 1037-1043.

Eley A, Pacey AA, Galdiero M, Galdiero M, Galdiero F. 2005. Can Chlamydia trachomatis directly damage your sperm? Lancet Infectious Disease 5, 53-57.

Elias P. 2007. The skin barrier as an innate immune element. Seminars in Immunopathology 29, 3–14. PMID: 17621950

Eschenbach DA, Thwin SS, Patton DL, Hooton TM, Stapleton AE, Agnew K, et al. 2000. Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clinical and Infectious Diseases Journal 30, 901–7.

Farage M, Maibach H. 2006. Lifetime changes in the vulva and vagina. Archive of Gynecology and Obstetric 273, 195–202.

Freinkel RK, Shen Y. 1969. The origin of free fatty acids in sebum. II. Assay of the lipases of the cutaneous bacteria and effects of pH. Journal of Investigative Dermatology 53, 422–7.

Gorkemli H, Cicek MN, Akyurek C, Celik C. 2006. Approach to infertile patient. In: Cicek MN, Akyurek C, Celik C. (Eds.), Gynecology and obstetrics. Chapter 29. Ankara, Turkey: Gunes Kitabevi pp. 1081.

Hawthorn LA, Bruce AW, Reid G. 1991. Ability of uropathogens to bind to Tamm Horsfall protein-coated renal tubular cells. Urological Research Journal 19, 301–4.

Hill GB. 1993. The microbiology of bacterial vaginosis. American Journal of Obstetric and Gynecology 169, 450-4.

Hillier S. 2005. The complexity of microbial diversity in bacterial vaginosis. The New England Journal of Medicine 353, 1886–7.

Hillier SL, Krohn MA, Rabe LK, Klebanoff SJ, Eschenbach DA. 1993. The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clinical and Infectious Disease Journal 16(Suppl 4), S273–81.

Hughes VL, Hillier SL. 1990. Microbiologic characteristics of Lactobacillus products used for colonization of the vagina. Obstetric and Gynecology Journal 75, 244–8.

Joesoef M, Schmid G, Hillier S. 1999. Bacterial vaginosis: Review of treatment options and potential clinical indications for therapy. Clinical Infectous Disease Journal 28(Suppl 1), S57–65.

Kabara JJ, Swieczkowski DM, Conley AJ, Truant JP. 1972. Fatty acids and derivatives as antimicrobial agents..Antimicrobial Agents and Chemotherapy Journal 2, 23–8.

Kamarashev JA, Vassileva SG. 1997. Dermatologic diseases of the vulva. Clinics in Dermatology 15, 53–65.

Karinen L, Pouta A, Hartikainen AL, Bloigu A, Paldanius M, Leinonen M, Saikku P, Jarvelin MR. 2004. Association between Chlamydia trachomatis antibodies and subfertility in the Northern Finland Birth Cohort 1966 (NFBC1966), at the age of 31 years. Epidemiology and Infection. Journal 132, 977-984.

Klebanoff MA, Nansel TR, Brotman RM, Zhang J, Yu KF, Schwebke JR, et al. 2010. Personal hygienic behaviors and bacterial vaginosis. Sexual Transmitted Disease 37, 94–9.

Lachlak N, Ageron E, Zampatti O, Michel G, Grimont PA. 1996. Composition of the Lactobacillus acidophilus complex isolated from vaginal flora. New Microbiology Journal 19, 123–32.

Lunenfeld B, Van Steirteghem A. 2004. Foundation Bertarelli. Infertility in the third millennium: implications for the individual, family and society: condensed meeting report from the Bertarelli Foundation’s second global conference. Human Reproduction. Update 10(4), 317-326.

McGregor JA, French JI, Jones W, Milligan K, McKinney PJ, Patterson E, et al. 1994. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: Results of a controlled trial of topical clindamycin cream. Amrican Journal of Obstetric and Gynecology 170, 1048–59.

Neri A, Sabah G, Samra Z. 1993. Bacterial vaginosis in pregnancy treated with yoghurt. Acta Obstetricia et Gynecologica Scandinavica 72, 17–9.

Niger J. 2014. Clinical Practice. Mar-Apr; 17(2), 154-8. doi: 10.4103/1119-3077.127424.

Nikhil Kumar, Beauty BeheraSai S SagiriKunal PalSirsendu S RaySaroj Roy. 2011. Bacterial vaginosis: Etiology and modalities of treatment—A brief note. Journal of Pharmacy and Bioallied Sciences. Oct-Dec 3(4), 496–503. DOI:10.4103/0975-7406.90102. PMCID: PMC3249696

Ochsendorf FR, Schill WB, Comhaire FH, Hargreave TB. 2006. Urethritis, sexually transmitted diseases (STD), acquired immuno-deficiency syndrome (AIDS). In Berlin –Heidelberg – New York, Andrology for the clinician. Springer pp. 125-130.

Otero CM, Nader-Macías EM. 2007. Lactobacillus adhesion to epithelial cells from bovine vagina. Communicating Current Research and Educational Topics and Trends in Applied Microbiology 2, 749–57.

Ouattara B, Simard RE, Holley RA, Piette GJ, Bégin A. 1997. Antibacterial activity of selected fatty acids and essential oils against six meat spoilage organisms. International Journal of Food Microbiology 37, 155–62.

Owen JA, Jr. 1975. Physiology of the menstrual cycle. Amrican Journal of Clinical Nutrition 28, 333–8.

Ryckman KK, Simhan HN, Krohn MA, Williams SM. 2009. Predicting risk of bacterial vaginosis: The role of race, smoking and corticotropin-releasing hormone-related genes.  Molecular Human Reproduction 15, 131–7.

Sakar MN, Gul T, Atay AE, Celik Y. 2008. Comparison of hysterosal pingography and laparoscopy in the evaluation of infertile Women, Saudi Medical Journal 29(9), 1315-1318.

Sobel JD, Ferris D, Schwebke J, Nyirjesy P, Wiesenfeld HC, Peipert J, et al. 2006. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Amarican Journal Obstetric and Gynecology 194, 1283–9.36.

Spiegel CG. 1991. Bacterial vaginosis. Clinical Microbiology Reviews Journal 4, 485–502. PMCID:PMC358214

Tasdemir M, Tasdemir I, Tasdemir S, Tavukcuoglu S. 1996. Alternative treatment for bacterial vaginosis in pregnant patients; restoration of vaginal acidity and flora. Archive of AIDS Research Journal 10, 239–41.

Vásquez A, Jakobsson T, Ahrné S, Forsum U, Molin G. 2002. Vaginal Lactobacillus flora of healthy Swedish women. Journal of Clinical Microbiology 40, 2746–9. PMCID:PMC120688

Zasloff M. 2002. Antimicrobial peptides of multicellular organisms. Nature Journal 415, 389–95. DOI:10.1038/415389a

Zhou X, Bent SJ, Schneider MG, Davis CC, Islam MR, Forney LJ. 2004. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology Journals 150, 2565–73.